Fulcrum Therapeutics's market cap is currently $207.66M. The company's EPS TTM is $-0.309; its P/E ratio is ―; Fulcrum Therapeutics is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 2.81M	$ 6.34M	$ 19.16M	$ 8.82M	$ 0.00
Gross Profit	$ 2.81M	$ 3.93M	$ 16.65M	$ 6.44M	$ -2.05M
Operating Income	$ -110.66M	$ -112.56M	$ -81.05M	$ -71.61M	$ -84.22M
EBITDA	$ -108.49M	$ -109.72M	$ -78.54M	$ -69.23M	$ -82.16M
Net Income	$ -97.33M	$ -105.62M	$ -78.33M	$ -68.44M	$ -79.11M
Balance Sheet
Cash & Short-Term Investments	$ 236.22M	$ 202.92M	$ 218.16M	$ 112.91M	$ 96.71M
Total Assets	$ 257.69M	$ 226.69M	$ 235.00M	$ 129.58M	$ 110.44M
Total Debt	$ 10.82M	$ 13.42M	$ 0.00	$ 17.00K	$ 50.00K
Net Debt	$ -14.74M	$ -21.68M	$ -35.41M	$ -57.03M	$ -96.66M
Total Liabilities	$ 22.50M	$ 27.74M	$ 23.46M	$ 34.40M	$ 23.29M
Stockholders' Equity	$ 235.19M	$ 198.94M	$ 211.54M	$ 95.18M	$ 87.15M
Cash Flow
Free Cash Flow	$ -91.47M	$ -99.01M	$ -80.19M	$ -55.00M	$ -40.34M
Operating Cash Flow	$ -90.97M	$ -97.05M	$ -78.48M	$ -53.66M	$ -39.48M
Investing Cash Flow	$ -36.69M	$ 12.41M	$ -129.67M	$ -57.14M	$ -944.00K
Financing Cash Flow	$ 118.12M	$ 84.32M	$ 186.51M	$ 71.13M	$ 64.34M

Currency in USD

Fulcrum Therapeutics Earnings and Revenue History

Income Statement >

Fulcrum Therapeutics Debt to Assets

Balance Sheet >

Fulcrum Therapeutics Cash Flow

Cash Flow >

Fulcrum Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing